Biden Administration Won’t Use March-In Rights On Prostate Cancer Drug
President Joe Biden’s administration has decided not to pursue an untested legal strategy that could dramatically lower the cost of medication for prostate cancer patients, angering key lawmakers who fear the administration is punting on challenging the power of the pharmaceutical industry. Patient advocates and progressives had hoped the administration would use its executive powers … Read more